Available Fin. (531310)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Reported P/E of 1.21 and PEG of 0.07 are statistically ultra-cheap if current earnings recur.
• Quarterly net profit of ₹27 Cr and profit growth of 28.97% show recent earnings momentum.
• Piotroski F-Score of 7/9 suggests decent financial health on reported metrics.
• Price is at the top of its 52-week range, reflecting strong market interest and positive sentiment.

Concerns

• P/B of 11.59 with book value of ₹20.44 means paying ₹236.85 for ₹20.44 of net assets, leaving no asset-based margin of safety.
• ROE of 1.14% and ROCE of 0.03% show the underlying capital earns almost nothing.
• Latest quarter shows ₹0 Cr sales alongside ₹27 Cr net profit, pointing to non-operating or one-off earnings.
• No dividend and N/A promoter holding reduce transparency and income support for shareholders.

AI Analysis

When I see a P/E of 1.21 and a PEG of 0.07, my first instinct is to reach for my wallet. But Graham taught me to look behind the numbers. Available Fin. reports a latest-quarter net profit of ₹27 Cr with sales of ₹0 Cr. That is not business income; it is an event. In financial services, such 'profits' often come from selling assets or marking positions, not from a durable franchise. The balance sheet tells a more sober story: book value is only ₹20.44 per share, but the market asks ₹236.85. That is 11.59 times book for an enterprise that earns just 1.14% on equity and 0.03% on capital. If I pay ₹236.85 for ₹20.44 of net assets, I need enormous future earnings to justify the price. The reported P/E implies annual earnings of roughly ₹205 Cr against a net worth of only ₹21 Cr. That is mathematically incompatible with a 1.14% ROE unless the earnings are non-recurring. Profit growth of 28.97% sounds attractive, but it is easy to grow profits from a base of almost nothing. The Piotroski F-Score of 7/9 is a point in its favour, but no score can turn a one-time gain into a perpetual cash machine. I would rather miss this apparent bargain than buy an earnings mirage. If the company can demonstrate recurring revenue, consistent capital allocation, and a return on equity above its cost of capital, then I will revisit. Until then, this is a pass. The margin of safety is not the low P/E; it is the difference between price and intrinsic value. I don't see that difference here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer